Loading...

Strong Solvency Ratio Will Support Acquisitions And Organic Expansion

Published
15 Feb 25
Updated
23 Apr 26
Views
129
23 Apr
€16.40
AnalystConsensusTarget's Fair Value
€17.72
7.4% undervalued intrinsic discount
Loading
1Y
1.5%
7D
1.2%

Author's Valuation

€17.727.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 23 Apr 26

COFA: Future Returns Will Rely On Dividend Policy And Slightly Lower Earnings Multiple

Analysts have trimmed their price target on COFACE by €0.30, reflecting a slightly lower view on valuation while keeping core assumptions around fair value and earnings metrics broadly unchanged.

Analyst Commentary

Sell side commentary around the €0.30 price target cut on COFACE points to only a mild reset in expectations, rather than a shift in the core thesis. The new target still reflects confidence in the earnings framework, while acknowledging areas where execution and valuation are being fine tuned.

Bullish Takeaways

  • Bullish analysts view the modest €0.30 reduction as a calibration of inputs rather than a change in the underlying earnings story, which they see as broadly intact.
  • There is an emphasis on core assumptions around fair value remaining stable, suggesting that the long term earnings power and business model are still considered supportive of current valuation work.
  • The limited size of the target move is read as a sign that analysts do not see a material shift in risk, execution quality or balance sheet resilience at this stage.
  • Some investors may interpret the small adjustment as an opportunity to reassess COFACE against peers where target changes have been more aggressive, especially for those focused on consistency of research views.

Bearish Takeaways

  • Bearish analysts may see the price target cut as a signal that the margin of safety in the valuation has narrowed, even if only slightly.
  • The move highlights that, while earnings assumptions are unchanged, there is less willingness to pay the prior implied multiple, suggesting a more cautious stance on future execution.
  • The fact that the target needed trimming at all can be viewed as a reminder that COFACE remains sensitive to shifts in sentiment around earnings quality and capital requirements.
  • For more cautious investors, the lower target could reinforce the view that upside is now more constrained relative to previous expectations, making timing and entry levels more important.

What's in the News

  • COFACE SA scheduled a Special and Extraordinary Shareholders Meeting for May 19, 2026, at 1 place Costes et Bellonte, Bois Colombes, France (Key Developments).
  • The company proposed a €1.25 dividend per share for the full year ended December 31, 2025, with a payout ratio of 84%, to be presented at the Shareholders Meeting, in line with its stated capital management policy (Key Developments).
  • A Board Meeting is planned for February 19, 2026, with the agenda to approve the consolidated financial statements as of December 31, 2025 (Key Developments).

Valuation Changes

  • Fair Value remains steady at €17.72, with no change between the previous and updated assessment.
  • The Discount Rate has fallen slightly from 7.76% to 7.73%, indicating a marginal adjustment in the required return used in the model.
  • Revenue Growth remains essentially unchanged at about 3.13% in both the earlier and updated assumptions.
  • The Net Profit Margin is stable at roughly 12.86%, with only a very small numerical adjustment in the updated input.
  • The Future P/E has edged down slightly from 12.02x to 12.01x, implying a marginally lower valuation multiple applied to forward earnings.
5 viewsusers have viewed this narrative update

Key Takeaways

  • Acquisitions and tech investments may enhance efficiencies and profitability, boosting revenue streams and long-term growth potential.
  • Strong client retention and financial solvency support consistent revenue and expansion opportunities through acquisitions and organic growth.
  • Economic volatility, rising insolvencies, and competitive pressures in insurance pose risks to profitability and consistent revenue growth for COFACE.

Catalysts

About COFACE
    Through its subsidiaries, provides credit insurance products and related services for microenterprises, small and medium enterprises, mid-market companies, international corporations, financial institutions, and clients of distribution partners.
What are the underlying business or industry changes driving this perspective?
  • The acquisition of Cedar Rose, a key information provider in the Middle East, is expected to enhance COFACE's information services capabilities, potentially boosting future revenue streams.
  • The continued investment in COFACE's business information (BI) venture and growth in the debt collection segment, both growing at double digits, indicate potential future earnings growth as these ventures scale.
  • The company's high client retention rate of 92.3% and selective growth strategy are likely to stabilize and potentially increase revenue, contributing to consistent revenue streams.
  • The deliberate investment in technology and data is expected to drive efficiencies and improve net margins over time, enhancing the overall profitability of the company.
  • COFACE's strong solvency ratio (196%), above the target range, provides a solid foundation for future growth activities, such as acquisitions and organic expansion, which can lead to increased earnings.
COFACE Earnings and Revenue Growth

COFACE Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming COFACE's revenue will grow by 3.1% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 11.5% today to 12.9% in 3 years time.
  • Analysts expect earnings to reach €273.0 million (and earnings per share of €1.83) by about April 2029, up from €222.0 million today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 12.1x on those 2029 earnings, up from 10.8x today. This future PE is greater than the current PE for the GB Insurance industry at 11.7x.
  • Analysts expect the number of shares outstanding to decline by 0.16% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.73%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • The company's total revenues are slightly down from 2023 at -0.6%, with insurance revenue specifically down 2.2%, potentially impacting the overall revenue and net margins.
  • The combined ratio has increased by 1.2 points, driven by a 3.6% increase in the cost ratio, which suggests ongoing cost pressures and investments that could impact net earnings.
  • The high rate of insolvencies, with numbers 20-30% higher than 2019, presents a risk to maintain profitability and manage claims, potentially affecting net margins.
  • Market volatility and slowing economies, particularly in Europe, add uncertainty that may prevent consistent revenue growth and affect net income.
  • Factoring and trade credit insurance businesses are facing competitive pressures and pricing declines, with a price effect at -1.4%, which could challenge future revenue generation and profit margins.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of €17.72 for COFACE based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €20.9, and the most bearish reporting a price target of just €15.7.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €2.1 billion, earnings will come to €273.0 million, and it would be trading on a PE ratio of 12.1x, assuming you use a discount rate of 7.7%.
  • Given the current share price of €16.1, the analyst price target of €17.72 is 9.1% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on COFACE?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives